United States Biotechnology & Medical Research

MapLight Therapeutics Inc (MPLT)

Track

Track

Over the past 90 days, MapLight Therapeutics saw 88 insider transactions, resulting in a net value of approximately $6.17 million. While Catalyst4, Inc. engaged in significant buying, executives recorded a net selling value of $9.29 million. These activities follow a 56.8% decline in stock price and a recent earnings report that missed expectations.
Ticker: MPLT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for MapLight Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Planned sale
Price
466.05
Quantity 18,809 +20.6%
Value US$1,719,413
2.6
Lillie James Woodruff Officer Officer
Transaction date
Proposed sale
Price
187.08
Quantity 83,437
Value US$3,890,972
2.6
Lillie James Woodruff Officer Officer
Transaction date
Proposed sale
Price
464.17
Quantity 16,160
Value US$2,651,700
2.3
Novo Holdings A/S Former Affiliate
Transaction date
Proposed sale
Price
15.02
Quantity 1,000
Value US$100,000
2.0
Catalyst4, Inc. Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 1,000 +5.0%
Value US$100,000
2.0
Catalyst4, Inc. Large shareholder
Transaction date
Purchase
Price
12.63
Quantity 1,000 +0.0%
Value US$100,000
2.0
Catalyst4, Inc. Large shareholder
Transaction date
Purchase
Price
11.69
Quantity 1,000 +0.3%
Value US$100,000
2.0
Catalyst4, Inc. Large shareholder
Transaction date
Purchase
Price
10.74
Quantity 1,000 +0.7%
Value US$100,000
0.7
Cox Troy Non-Executive Director
Transaction date
Purchase
Price
9.52
Quantity 1,000 +inf%
Value US$100,000
2.4
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Planned sale
Price
38.39
Quantity 200 -0.1%
Value US$7,678
2.4
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Planned sale
Price
37.70
Quantity 14,140 -7.5%
Value US$533,078
2.4
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Planned sale
Price
37.05
Quantity 2,833 -1.5%
Value US$104,963
2.4
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Planned sale
Price
38.17
Quantity 900 -0.6%
Value US$34,353
2.4
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Planned sale
Price
37.61
Quantity 16,969 -10.5%
Value US$638,204
2.4
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Planned sale
Price
36.51
Quantity 600 -0.4%
Value US$21,906
2.6
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
37.90
Quantity 16,779 -1.3%
Value US$635,924
2.6
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
37.90
Quantity 2,077 -0.9%
Value US$78,718
2.6
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
37.90
Quantity 1,130 -0.8%
Value US$42,827
2.6
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
37.90
Quantity 3,656 -1.2%
Value US$138,562
2.4
ANATOL KREITZER Officer Officer
Transaction date
Proposed sale
Price
37.22
Quantity 17,173
Value US$639,179
2.4
JONATHAN GILLIS Officer Officer
Transaction date
Proposed sale
Price
37.22
Quantity 18,469
Value US$687,416
2.4
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Sale
Price
37.44
Quantity 1,592 -0.8%
Value US$59,604
2.4
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Sale
Price
36.66
Quantity 7,464 -3.7%
Value US$273,630
2.4
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Sale
Price
37.44
Quantity 1,476 -0.9%
Value US$55,261
2.4
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Sale
Price
36.66
Quantity 6,979 -4.1%
Value US$255,850
2.6
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
37.96
Quantity 92 -0.0%
Value US$3,492
2.6
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
37.26
Quantity 28,091 -2.2%
Value US$1,046,671
2.6
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
36.46
Quantity 40,899 -3.1%
Value US$1,491,178
2.6
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
37.96
Quantity 12 -0.0%
Value US$456
2.6
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
37.26
Quantity 3,526 -1.5%
Value US$131,379
2.6
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
36.45
Quantity 5,009 -2.1%
Value US$182,578
2.6
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
37.96
Quantity 11 -0.0%
Value US$418
2.6
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
37.26
Quantity 3,331 -2.2%
Value US$124,113
2.6
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
36.45
Quantity 4,776 -3.1%
Value US$174,085
2.6
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
37.96
Quantity 19 -0.0%
Value US$721
2.6
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
37.26
Quantity 5,865 -1.9%
Value US$218,530
2.6
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
36.46
Quantity 9,163 -2.9%
Value US$334,083
2.4
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Sale
Price
36.94
Quantity 4,510 -2.2%
Value US$166,599
2.4
Kreitzer Anatol Chief Discovery Officer Officer
Transaction date
Sale
Price
36.13
Quantity 5,545 -2.6%
Value US$200,341
2.4
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Sale
Price
36.94
Quantity 4,699 -2.7%
Value US$173,581
2.4
GILLIS JONATHAN CAO and Interim CFO Officer
Transaction date
Sale
Price
36.13
Quantity 5,356 -3.0%
Value US$193,512
2.6
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
37.54
Quantity 90 -0.0%
Value US$3,379
2.6
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
36.99
Quantity 42,738 -3.1%
Value US$1,580,879
2.6
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Sale
Price
36.00
Quantity 18,950 -1.4%
Value US$682,200
2.6
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
37.54
Quantity 12 -0.0%
Value US$450
2.6
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
36.99
Quantity 5,393 -2.2%
Value US$199,487
2.6
Lillie James Woodruff Chief Scientific Officer Officer
Transaction date
Sale
Price
36.00
Quantity 2,238 -0.9%
Value US$80,568
2.6
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
37.54
Quantity 10 -0.0%
Value US$375
2.6
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
36.99
Quantity 5,103 -3.2%
Value US$188,760
2.6
Hanson Kristopher General Counsel Officer
Transaction date
Sale
Price
36.00
Quantity 2,147 -1.3%
Value US$77,292
2.6
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
37.54
Quantity 18 -0.0%
Value US$676
2.6
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
36.99
Quantity 8,972 -2.7%
Value US$331,874
2.6
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Sale
Price
36.00
Quantity 4,465 -1.3%
Value US$160,740
2.6
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Planned sale
Price
37.04
Quantity 7,845 -2.3%
Value US$290,579
2.6
Foff Erin Pennock Chief Medical Officer Officer
Transaction date
Planned sale
Price
36.16
Quantity 7,155 -2.1%
Value US$258,725
2.4
Anatol Kreitzer Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 36,284
Value US$1,375,526
2.4
Jonathan Gillis Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 36,979
Value US$1,401,874
2.4
Anatol Kreitzer Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 33,605
Value US$1,273,966
2.6
Foff Erin Pennock Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 48,158
Value US$1,825,670
1.4
ROBERT MALENKA Director Non-Executive Director
Transaction date
Proposed sale
Price
37.91
Quantity 17,537
Value US$664,828
2.6
Kroeger Christopher A. Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 152,230
Value US$5,771,039
2.6
Hanson Kristopher Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 16,508
Value US$625,818
2.6
Lillie James Woodruff Officer Officer
Transaction date
Proposed sale
Price
37.91
Quantity 18,835
Value US$714,035
2.6
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
28.15
Quantity 198 -0.0%
Value US$5,574
2.6
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.19
Quantity 118,037 -7.8%
Value US$3,209,426
2.6
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
30.56
Quantity 5,890 -0.4%
Value US$179,998
2.6
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
30.04
Quantity 6,871 -0.5%
Value US$206,405
2.6
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
28.70
Quantity 877 -0.1%
Value US$25,170
2.6
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.57
Quantity 342 -0.0%
Value US$9,429
2.6
Hanson Kristopher General Counsel Officer
Transaction date
Planned sale
Price
30.56
Quantity 5,808 -3.5%
Value US$177,492
2.6
Hanson Kristopher General Counsel Officer
Transaction date
Planned sale
Price
30.04
Quantity 6,979 -4.0%
Value US$209,649
2.6
Hanson Kristopher General Counsel Officer
Transaction date
Planned sale
Price
28.70
Quantity 846 -0.5%
Value US$24,280
2.6
Hanson Kristopher General Counsel Officer
Transaction date
Planned sale
Price
27.61
Quantity 284 -0.2%
Value US$7,841
2.6
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
29.20
Quantity 3,205 -0.2%
Value US$93,586
2.6
Kroeger Christopher A. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
28.56
Quantity 1,582 -0.1%
Value US$45,182
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-04 2026-08-03 PlS Planned sale
2.6
Lillie James Woodruff

Chief Scientific Officer

Officer
18,809 +20.6%
466.05
US$1,719,413 		18,809 +20.6% 466.05 US$1,719,413
2026-08-03 2026-08-03 PrS Proposed sale
2.6
Lillie James Woodruff

Officer

Officer
83,437
187.08
US$3,890,972 		83,437 187.08 US$3,890,972
2026-08-03 2026-08-03 PrS Proposed sale
2.6
Lillie James Woodruff

Officer

Officer
16,160
464.17
US$2,651,700 		16,160 464.17 US$2,651,700
2026-07-30 2026-07-30 PrS Proposed sale
2.3
Novo Holdings A/S

Former Affiliate
1,000
15.02
US$100,000 		1,000 15.02 US$100,000
2026-07-30 2026-07-30 B Purchase
2.0
Catalyst4, Inc.
Large shareholder
1,000 +5.0%
13.00
US$100,000 		1,000 +5.0% 13.00 US$100,000
2026-07-30 2026-07-29 B Purchase
2.0
Catalyst4, Inc.
Large shareholder
1,000 +0.0%
12.63
US$100,000 		1,000 +0.0% 12.63 US$100,000
2026-07-30 2026-07-28 B Purchase
2.0
Catalyst4, Inc.
Large shareholder
1,000 +0.3%
11.69
US$100,000 		1,000 +0.3% 11.69 US$100,000
2026-07-30 2026-07-28 B Purchase
2.0
Catalyst4, Inc.
Large shareholder
1,000 +0.7%
10.74
US$100,000 		1,000 +0.7% 10.74 US$100,000
2026-07-28 2026-07-28 B Purchase
0.7
Cox Troy
Non-Executive Director
1,000 +inf%
9.52
US$100,000 		1,000 +inf% 9.52 US$100,000
2026-07-20 2026-07-17 PlS Planned sale
2.4
Kreitzer Anatol

Chief Discovery Officer

Officer
200 -0.1%
38.39
US$7,678 		200 -0.1% 38.39 US$7,678
2026-07-20 2026-07-17 PlS Planned sale
2.4
Kreitzer Anatol

Chief Discovery Officer

Officer
14,140 -7.5%
37.70
US$533,078 		14,140 -7.5% 37.70 US$533,078
2026-07-20 2026-07-17 PlS Planned sale
2.4
Kreitzer Anatol

Chief Discovery Officer

Officer
2,833 -1.5%
37.05
US$104,963 		2,833 -1.5% 37.05 US$104,963
2026-07-20 2026-07-17 PlS Planned sale
2.4
GILLIS JONATHAN

CAO and Interim CFO

Officer
900 -0.6%
38.17
US$34,353 		900 -0.6% 38.17 US$34,353
2026-07-20 2026-07-17 PlS Planned sale
2.4
GILLIS JONATHAN

CAO and Interim CFO

Officer
16,969 -10.5%
37.61
US$638,204 		16,969 -10.5% 37.61 US$638,204
2026-07-20 2026-07-17 PlS Planned sale
2.4
GILLIS JONATHAN

CAO and Interim CFO

Officer
600 -0.4%
36.51
US$21,906 		600 -0.4% 36.51 US$21,906
2026-07-17 2026-07-17 S Sale
2.6
Kroeger Christopher A.

Chief Executive Officer

Executive Director
16,779 -1.3%
37.90
US$635,924 		16,779 -1.3% 37.90 US$635,924
2026-07-17 2026-07-17 S Sale
2.6
Lillie James Woodruff

Chief Scientific Officer

Officer
2,077 -0.9%
37.90
US$78,718 		2,077 -0.9% 37.90 US$78,718
2026-07-17 2026-07-17 S Sale
2.6
Hanson Kristopher

General Counsel

Officer
1,130 -0.8%
37.90
US$42,827 		1,130 -0.8% 37.90 US$42,827
2026-07-17 2026-07-17 S Sale
2.6
Foff Erin Pennock

Chief Medical Officer

Officer
3,656 -1.2%
37.90
US$138,562 		3,656 -1.2% 37.90 US$138,562
2026-07-17 2026-07-17 PrS Proposed sale
2.4
ANATOL KREITZER

Officer

Officer
17,173
37.22
US$639,179 		17,173 37.22 US$639,179
2026-07-17 2026-07-17 PrS Proposed sale
2.4
JONATHAN GILLIS

Officer

Officer
18,469
37.22
US$687,416 		18,469 37.22 US$687,416
2026-07-20 2026-07-16 S Sale
2.4
Kreitzer Anatol

Chief Discovery Officer

Officer
1,592 -0.8%
37.44
US$59,604 		1,592 -0.8% 37.44 US$59,604
2026-07-20 2026-07-16 S Sale
2.4
Kreitzer Anatol

Chief Discovery Officer

Officer
7,464 -3.7%
36.66
US$273,630 		7,464 -3.7% 36.66 US$273,630
2026-07-20 2026-07-16 S Sale
2.4
GILLIS JONATHAN

CAO and Interim CFO

Officer
1,476 -0.9%
37.44
US$55,261 		1,476 -0.9% 37.44 US$55,261
2026-07-20 2026-07-16 S Sale
2.4
GILLIS JONATHAN

CAO and Interim CFO

Officer
6,979 -4.1%
36.66
US$255,850 		6,979 -4.1% 36.66 US$255,850
2026-07-17 2026-07-16 S Sale
2.6
Kroeger Christopher A.

Chief Executive Officer

Executive Director
92 -0.0%
37.96
US$3,492 		92 -0.0% 37.96 US$3,492
2026-07-17 2026-07-16 S Sale
2.6
Kroeger Christopher A.

Chief Executive Officer

Executive Director
28,091 -2.2%
37.26
US$1,046,671 		28,091 -2.2% 37.26 US$1,046,671
2026-07-17 2026-07-16 S Sale
2.6
Kroeger Christopher A.

Chief Executive Officer

Executive Director
40,899 -3.1%
36.46
US$1,491,178 		40,899 -3.1% 36.46 US$1,491,178
2026-07-17 2026-07-16 S Sale
2.6
Lillie James Woodruff

Chief Scientific Officer

Officer
12 -0.0%
37.96
US$456 		12 -0.0% 37.96 US$456
2026-07-17 2026-07-16 S Sale
2.6
Lillie James Woodruff

Chief Scientific Officer

Officer
3,526 -1.5%
37.26
US$131,379 		3,526 -1.5% 37.26 US$131,379
2026-07-17 2026-07-16 S Sale
2.6
Lillie James Woodruff

Chief Scientific Officer

Officer
5,009 -2.1%
36.45
US$182,578 		5,009 -2.1% 36.45 US$182,578
2026-07-17 2026-07-16 S Sale
2.6
Hanson Kristopher

General Counsel

Officer
11 -0.0%
37.96
US$418 		11 -0.0% 37.96 US$418
2026-07-17 2026-07-16 S Sale
2.6
Hanson Kristopher

General Counsel

Officer
3,331 -2.2%
37.26
US$124,113 		3,331 -2.2% 37.26 US$124,113
2026-07-17 2026-07-16 S Sale
2.6
Hanson Kristopher

General Counsel

Officer
4,776 -3.1%
36.45
US$174,085 		4,776 -3.1% 36.45 US$174,085
2026-07-17 2026-07-16 S Sale
2.6
Foff Erin Pennock

Chief Medical Officer

Officer
19 -0.0%
37.96
US$721 		19 -0.0% 37.96 US$721
2026-07-17 2026-07-16 S Sale
2.6
Foff Erin Pennock

Chief Medical Officer

Officer
5,865 -1.9%
37.26
US$218,530 		5,865 -1.9% 37.26 US$218,530
2026-07-17 2026-07-16 S Sale
2.6
Foff Erin Pennock

Chief Medical Officer

Officer
9,163 -2.9%
36.46
US$334,083 		9,163 -2.9% 36.46 US$334,083
2026-07-20 2026-07-15 S Sale
2.4
Kreitzer Anatol

Chief Discovery Officer

Officer
4,510 -2.2%
36.94
US$166,599 		4,510 -2.2% 36.94 US$166,599
2026-07-20 2026-07-15 S Sale
2.4
Kreitzer Anatol

Chief Discovery Officer

Officer
5,545 -2.6%
36.13
US$200,341 		5,545 -2.6% 36.13 US$200,341
2026-07-20 2026-07-15 S Sale
2.4
GILLIS JONATHAN

CAO and Interim CFO

Officer
4,699 -2.7%
36.94
US$173,581 		4,699 -2.7% 36.94 US$173,581
2026-07-20 2026-07-15 S Sale
2.4
GILLIS JONATHAN

CAO and Interim CFO

Officer
5,356 -3.0%
36.13
US$193,512 		5,356 -3.0% 36.13 US$193,512
2026-07-17 2026-07-15 S Sale
2.6
Kroeger Christopher A.

Chief Executive Officer

Executive Director
90 -0.0%
37.54
US$3,379 		90 -0.0% 37.54 US$3,379
2026-07-17 2026-07-15 S Sale
2.6
Kroeger Christopher A.

Chief Executive Officer

Executive Director
42,738 -3.1%
36.99
US$1,580,879 		42,738 -3.1% 36.99 US$1,580,879
2026-07-17 2026-07-15 S Sale
2.6
Kroeger Christopher A.

Chief Executive Officer

Executive Director
18,950 -1.4%
36.00
US$682,200 		18,950 -1.4% 36.00 US$682,200
2026-07-17 2026-07-15 S Sale
2.6
Lillie James Woodruff

Chief Scientific Officer

Officer
12 -0.0%
37.54
US$450 		12 -0.0% 37.54 US$450
2026-07-17 2026-07-15 S Sale
2.6
Lillie James Woodruff

Chief Scientific Officer

Officer
5,393 -2.2%
36.99
US$199,487 		5,393 -2.2% 36.99 US$199,487
2026-07-17 2026-07-15 S Sale
2.6
Lillie James Woodruff

Chief Scientific Officer

Officer
2,238 -0.9%
36.00
US$80,568 		2,238 -0.9% 36.00 US$80,568
2026-07-17 2026-07-15 S Sale
2.6
Hanson Kristopher

General Counsel

Officer
10 -0.0%
37.54
US$375 		10 -0.0% 37.54 US$375
2026-07-17 2026-07-15 S Sale
2.6
Hanson Kristopher

General Counsel

Officer
5,103 -3.2%
36.99
US$188,760 		5,103 -3.2% 36.99 US$188,760
2026-07-17 2026-07-15 S Sale
2.6
Hanson Kristopher

General Counsel

Officer
2,147 -1.3%
36.00
US$77,292 		2,147 -1.3% 36.00 US$77,292
2026-07-17 2026-07-15 S Sale
2.6
Foff Erin Pennock

Chief Medical Officer

Officer
18 -0.0%
37.54
US$676 		18 -0.0% 37.54 US$676
2026-07-17 2026-07-15 S Sale
2.6
Foff Erin Pennock

Chief Medical Officer

Officer
8,972 -2.7%
36.99
US$331,874 		8,972 -2.7% 36.99 US$331,874
2026-07-17 2026-07-15 S Sale
2.6
Foff Erin Pennock

Chief Medical Officer

Officer
4,465 -1.3%
36.00
US$160,740 		4,465 -1.3% 36.00 US$160,740
2026-07-17 2026-07-15 PlS Planned sale
2.6
Foff Erin Pennock

Chief Medical Officer

Officer
7,845 -2.3%
37.04
US$290,579 		7,845 -2.3% 37.04 US$290,579
2026-07-17 2026-07-15 PlS Planned sale
2.6
Foff Erin Pennock

Chief Medical Officer

Officer
7,155 -2.1%
36.16
US$258,725 		7,155 -2.1% 36.16 US$258,725
2026-07-15 2026-07-15 PrS Proposed sale
2.4
Anatol Kreitzer

Officer

Officer
36,284
37.91
US$1,375,526 		36,284 37.91 US$1,375,526
2026-07-15 2026-07-15 PrS Proposed sale
2.4
Jonathan Gillis

Officer

Officer
36,979
37.91
US$1,401,874 		36,979 37.91 US$1,401,874
2026-07-15 2026-07-15 PrS Proposed sale
2.4
Anatol Kreitzer

Officer

Officer
33,605
37.91
US$1,273,966 		33,605 37.91 US$1,273,966
2026-07-15 2026-07-15 PrS Proposed sale
2.6
Foff Erin Pennock

Officer

Officer
48,158
37.91
US$1,825,670 		48,158 37.91 US$1,825,670
2026-07-15 2026-07-15 PrS Proposed sale
1.4
ROBERT MALENKA

Director

Non-Executive Director
17,537
37.91
US$664,828 		17,537 37.91 US$664,828
2026-07-15 2026-07-15 PrS Proposed sale
2.6
Kroeger Christopher A.

Officer

Officer
152,230
37.91
US$5,771,039 		152,230 37.91 US$5,771,039
2026-07-15 2026-07-15 PrS Proposed sale
2.6
Hanson Kristopher

Officer

Officer
16,508
37.91
US$625,818 		16,508 37.91 US$625,818
2026-07-15 2026-07-15 PrS Proposed sale
2.6
Lillie James Woodruff

Officer

Officer
18,835
37.91
US$714,035 		18,835 37.91 US$714,035
2026-05-18 2026-05-18 PlS Planned sale
2.6
Kroeger Christopher A.

Chief Executive Officer

Executive Director
198 -0.0%
28.15
US$5,574 		198 -0.0% 28.15 US$5,574
2026-05-18 2026-05-18 PlS Planned sale
2.6
Kroeger Christopher A.

Chief Executive Officer

Executive Director
118,037 -7.8%
27.19
US$3,209,426 		118,037 -7.8% 27.19 US$3,209,426
2026-05-11 2026-05-11 PlS Planned sale
2.6
Kroeger Christopher A.

Chief Executive Officer

Executive Director
5,890 -0.4%
30.56
US$179,998 		5,890 -0.4% 30.56 US$179,998
2026-05-11 2026-05-11 PlS Planned sale
2.6
Kroeger Christopher A.

Chief Executive Officer

Executive Director
6,871 -0.5%
30.04
US$206,405 		6,871 -0.5% 30.04 US$206,405
2026-05-11 2026-05-11 PlS Planned sale
2.6
Kroeger Christopher A.

Chief Executive Officer

Executive Director
877 -0.1%
28.70
US$25,170 		877 -0.1% 28.70 US$25,170
2026-05-11 2026-05-11 PlS Planned sale
2.6
Kroeger Christopher A.

Chief Executive Officer

Executive Director
342 -0.0%
27.57
US$9,429 		342 -0.0% 27.57 US$9,429
2026-05-11 2026-05-11 PlS Planned sale
2.6
Hanson Kristopher

General Counsel

Officer
5,808 -3.5%
30.56
US$177,492 		5,808 -3.5% 30.56 US$177,492
2026-05-11 2026-05-11 PlS Planned sale
2.6
Hanson Kristopher

General Counsel

Officer
6,979 -4.0%
30.04
US$209,649 		6,979 -4.0% 30.04 US$209,649
2026-05-11 2026-05-11 PlS Planned sale
2.6
Hanson Kristopher

General Counsel

Officer
846 -0.5%
28.70
US$24,280 		846 -0.5% 28.70 US$24,280
2026-05-11 2026-05-11 PlS Planned sale
2.6
Hanson Kristopher

General Counsel

Officer
284 -0.2%
27.61
US$7,841 		284 -0.2% 27.61 US$7,841
2026-05-11 2026-05-08 PlS Planned sale
2.6
Kroeger Christopher A.

Chief Executive Officer

Executive Director
3,205 -0.2%
29.20
US$93,586 		3,205 -0.2% 29.20 US$93,586
2026-05-11 2026-05-08 PlS Planned sale
2.6
Kroeger Christopher A.

Chief Executive Officer

Executive Director
1,582 -0.1%
28.56
US$45,182 		1,582 -0.1% 28.56 US$45,182
Explore more

More insider trading research around MapLight Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America